Position in DHR
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$30,052,029
+$1,688,438 QoQ
Shares Held
157,770
+5.5% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.69%
of 13F equity value
Holder Rank
#283
of 2,098 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Banque Transatlantique SA holds $65,760,492 across 12 Diagnostics & Research names. DHR ranks #2 (45.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
60,316 | $30,240,029 | |
| 2 | DHR |
Danaher Corp /De/
This page
|
157,770 | $30,052,029 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
4,400 | $2,316,336 | |
| 4 | NTRA |
Natera, Inc.
|
6,656 | $1,806,771 | |
| 5 | MTD |
Mettler Toledo International Inc/
|
750 | $958,132 | |
| 6 | QGEN |
Qiagen N.V.
|
4,064 | $158,902 | |
| 7 | RVTY |
Revvity, Inc.
|
775 | $86,226 | |
| 8 | A |
Agilent Technologies, Inc.
|
400 | $53,132 |
All Filings in DHR
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,052,029 | 157,770 | Shares | Defined | 2026-07-30 | |
| 2026-03-31 | $28,363,591 | 149,597 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $39,786,982 | 173,803 | Shares | Defined | 2026-02-26 | |
| 2025-09-30 | $45,136,664 | 227,664 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $46,572,820 | 235,764 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $48,902,750 | 238,550 | Shares | Defined | 2025-09-09 | |
| 2024-12-31 | $59,130,932 | 257,595 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||